Hiroki Ozawa

4.0k total citations
163 papers, 3.0k citations indexed

About

Hiroki Ozawa is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hiroki Ozawa has authored 163 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 28 papers in Oncology and 26 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hiroki Ozawa's work include Neuroscience and Neuropharmacology Research (17 papers), Bone health and treatments (16 papers) and Bone Metabolism and Diseases (14 papers). Hiroki Ozawa is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Bone health and treatments (16 papers) and Bone Metabolism and Diseases (14 papers). Hiroki Ozawa collaborates with scholars based in Japan, United States and Germany. Hiroki Ozawa's co-authors include Norio Amizuka, Mark M. Rasenick, Toshikazu Saito, T Nakajima, Sadakazu Ejiri, Kazuto Hoshi, Nobutaka Funa, Sueharu Horinouchi, Shoji Kohno and Mikako Tanaka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hiroki Ozawa

147 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Ozawa Japan 32 1.4k 568 508 334 291 163 3.0k
Annette Schmidt Germany 34 1.5k 1.1× 332 0.6× 227 0.4× 109 0.3× 109 0.4× 169 4.2k
Atsuko Mizuno Japan 31 2.4k 1.7× 948 1.7× 811 1.6× 264 0.8× 395 1.4× 49 5.3k
José Brás United States 45 1.6k 1.1× 500 0.9× 860 1.7× 513 1.5× 161 0.6× 146 6.0k
Akifumi Togari Japan 39 2.5k 1.8× 780 1.4× 1.8k 3.5× 437 1.3× 497 1.7× 148 5.7k
Donald A. Young United States 27 1.5k 1.0× 402 0.7× 224 0.4× 263 0.8× 156 0.5× 74 3.9k
Arthur D. Conigrave Australia 44 2.7k 1.9× 429 0.8× 829 1.6× 155 0.5× 240 0.8× 131 5.4k
James E. Carroll United States 33 1.4k 1.0× 194 0.3× 507 1.0× 183 0.5× 150 0.5× 107 3.8k
Vijay K. Yadav United States 27 1.6k 1.2× 514 0.9× 294 0.6× 168 0.5× 593 2.0× 55 3.7k
Mei Huang China 34 1.6k 1.1× 168 0.3× 1.0k 2.1× 86 0.3× 130 0.4× 98 3.0k

Countries citing papers authored by Hiroki Ozawa

Since Specialization
Citations

This map shows the geographic impact of Hiroki Ozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Ozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Ozawa more than expected).

Fields of papers citing papers by Hiroki Ozawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Ozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Ozawa. The network helps show where Hiroki Ozawa may publish in the future.

Co-authorship network of co-authors of Hiroki Ozawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Ozawa. A scholar is included among the top collaborators of Hiroki Ozawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Ozawa. Hiroki Ozawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shigeta, Keisuke, Hiroshi Hongo, Sheng‐Yu Ku, et al.. (2025). MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy. JCI Insight. 10(14). 1 indexed citations
2.
Takamori, Shinkichi, Hideko Isozaki, Keisuke Shigeta, et al.. (2025). Activation of APOBEC3 cytidine deaminases and endogenous retroviruses is integrated by MUC1-C in NSCLC cells. Cell Death Discovery. 11(1). 372–372.
3.
Takamori, Shinkichi, Atrayee Bhattacharya, Chie Kikutake, et al.. (2025). MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer. Signal Transduction and Targeted Therapy. 10(1). 389–389.
4.
Haratake, Naoki, Atrayee Bhattacharya, Weipu Mao, et al.. (2024). IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS. Cancer Research Communications. 4(5). 1268–1281. 4 indexed citations
5.
Kudo‐Saito, Chie, Hiroshi Imazeki, Hiroki Ozawa, et al.. (2024). Targeting SNCA in the treatment of malignant ascites in gastrointestinal cancer. Translational Oncology. 48. 102075–102075.
6.
Haratake, Naoki, Hiroki Ozawa, Yoshihiro Morimoto, et al.. (2023). Abstract B089: MUC1-C is a common driver of acquired osimertinb resistance in NSCLC. Molecular Cancer Therapeutics. 22(12_Supplement). B089–B089. 2 indexed citations
7.
Yamamoto, Naoki, Hirokazu Kumazaki, Sumihisa Honda, et al.. (2022). Game‐related behaviors among children and adolescents after school closure during the COVID‐19 pandemic: A cross‐sectional study. SHILAP Revista de lepidopterología. 1(3). e37–e37. 2 indexed citations
8.
Enomoto, Takayuki, Nobuaki Shiraki, Taiho Kambe, et al.. (2022). Methionine metabolism regulates pluripotent stem cell pluripotency and differentiation through zinc mobilization. Cell Reports. 40(3). 111120–111120. 13 indexed citations
9.
Imamura, Akira, et al.. (2022). The effectiveness of lamotrigine for persistent depressive disorder: A case report. Neuropsychopharmacology Reports. 42(1). 120–123. 4 indexed citations
10.
Yamamoto, Naoki, et al.. (2022). Intracranial calcification and psychotic symptoms after irradiation in a patient with Fanconi anemia: A case report. SHILAP Revista de lepidopterología. 1(2). e10–e10. 1 indexed citations
11.
Ozawa, Hiroki, Satoshi Murakami, Tetsuya Handa, et al.. (2022). Transient Methionine Deprivation Triggers Histone Modification and Potentiates Differentiation of Induced Pluripotent Stem Cells. Stem Cells. 41(3). 271–286. 6 indexed citations
12.
Nakano, Takeshi, et al.. (2021). Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report. Neuropsychopharmacology Reports. 41(3). 440–443. 3 indexed citations
13.
Ozawa, Hiroki, Hiroshi Imazeki, Hirofumi Kawakubo, et al.. (2021). Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer. Translational Oncology. 16. 101307–101307. 6 indexed citations
14.
Ono, Shinji, et al.. (2020). Genetic and epigenetic analyses of panic disorder in the post-GWAS era. Journal of Neural Transmission. 127(11). 1517–1526. 5 indexed citations
15.
Honda, Sumihisa, et al.. (2006). Association between Mothers' Concern about Child Rearing and Their Parenting Stress. Acta medica Nagasakiensia. 51(4). 115–120. 2 indexed citations
16.
Nakane, Yoshibumi, et al.. (2005). Nagasaki Schizophrenia Study: Influence of the Duration of Untreated Psychosis on Long-Term Outcome. Acta medica Nagasakiensia. 50(1). 17–22. 6 indexed citations
17.
Tateno, Masaru, Wataru Ukai, Hiroki Ozawa, et al.. (2004). Ethanol Inhibition of Neural Stem Cell Differentiation Is Reduced by Neurotrophic Factors. Alcoholism Clinical and Experimental Research. 28(Supplement). 134S–138S. 36 indexed citations
18.
Yamamoto, Megumi, Mario E. Götz, Hiroki Ozawa, et al.. (2000). Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer’s disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1535(1). 60–68. 44 indexed citations
19.
Ozawa, Hiroki, Wataru Ukai, Johannes Kornhuber, et al.. (1999). Postnatal ontogeny of GTP binding protein in the human frontal cortex. Life Sciences. 65(22). 2315–2323. 3 indexed citations
20.
Sohma, Hitoshi, Eri Hashimoto, Hiroki Ozawa, et al.. (1999). Quantitative reduction of type I adenylyl cyclase in human alcoholics. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1454(1). 11–18. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette Schmidt Breakdown of academic impact, for papers by Atsuko Mizuno Breakdown of academic impact, for papers by José Brás Breakdown of academic impact, for papers by Akifumi Togari Breakdown of academic impact, for papers by Donald A. Young Breakdown of academic impact, for papers by Arthur D. Conigrave Breakdown of academic impact, for papers by James E. Carroll Breakdown of academic impact, for papers by Vijay K. Yadav Breakdown of academic impact, for papers by Mei Huang
Rankless by CCL
2026